• Jean-Michel Liet, Julien Baleine, Pierre Demaret, Sophie Mounier, Florence Porcheret, Nicolas Joram, and Alexis Chenouard.
• Division of Pediatric Critical Care Medicine, Department of Neonatal Medicine and Pediatric Intensive Care, University Hospital of Nantes, Nantes, France.
• Pediatr Crit Care Me. 2022 Sep 1; 23 (9): e429e433e429-e433.

ObjectivesTo review use of semiautomated regional citrate anticoagulation (saRCA) for continuous kidney replacement therapy (CKRT) in young children.DesignRetrospective cohort study.SettingThree independent PICUs.PatientsAll consecutive children weighing less than 11 kg who received CKRT with saRCA from January 2015 to June 2020.InterventionsNone.Measurements And Main ResultsTwenty-one children weighing less than 11 kg underwent CKRT with saRCA. The total duration of the CKRT was 2,014 hours, with a total of 64 CKRT sessions. Citrate intoxication occurred in four of 64 CKRT sessions (6%). Citrate intoxication was consistently observed in the few CKRT sessions where the initial lactate concentration was greater than 4 mmol/L or the ratio of replacement fluid flow to citrate flow less than 50%. The rate of unscheduled interruptions of CKRT sessions was 25% (16/64).ConclusionsWe have used saRCA for CKRT in children weighing less than 11 kg. A strict protocol and intensive training are required to minimize complications.Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

18 keywords...

hide…